| The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug M Juarez, A Schcolnik-Cabrera, A Dueñas-Gonzalez American journal of cancer research 8 (2), 317, 2018 | 229 | 2018 |
| Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy A Schcolnik-Cabrera, A Chávez-Blanco, G Domínguez-Gómez, ... Expert opinion on investigational drugs 27 (5), 475-489, 2018 | 93 | 2018 |
| Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes A Schcolnik-Cabrera, B Oldak, M Juárez, M Cruz-Rivera, A Flisser, ... Apoptosis 24, 245-255, 2019 | 82 | 2019 |
| Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects M Guevara-Cruz, ET Godinez-Salas, M Sanchez-Tapia, ... BMJ Open Diabetes Research and Care 8 (1), e000948, 2020 | 74 | 2020 |
| Understanding tumor anabolism and patient catabolism in cancer-associated cachexia A Schcolnik-Cabrera, A Chávez-Blanco, G Domínguez-Gómez, ... American journal of cancer research 7 (5), 1107, 2017 | 69 | 2017 |
| Exploring the drug repurposing versatility of valproic acid as a multifunctional regulator of innate and adaptive immune cells R Soria-Castro, A Schcolnik-Cabrera, G Rodríguez-López, ... Journal of immunology research 2019, 2019 | 64 | 2019 |
| Perspectives on drug repurposing A Schcolnik-Cabrera, D Juárez-López, A Duenas-Gonzalez Current Medicinal Chemistry 28 (11), 2085-2099, 2021 | 26 | 2021 |
| Drug repurposing: considerations to surpass while re-directing old compounds for new treatments D Juárez-López, A Schcolnik-Cabrera Archives of Medical Research 52 (3), 243-251, 2021 | 24 | 2021 |
| Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug M Juarez, A Schcolnik-Cabrera, G Dominguez-Gomez, A Chavez-Blanco, ... Cancer Chemotherapy and Pharmacology 85, 1153-1163, 2020 | 23 | 2020 |
| Angiotensin-(1-7) induces beige fat thermogenesis through the Mas receptor A Vargas-Castillo, S Tobon-Cornejo, L Del Valle-Mondragon, ... Metabolism 103, 154048, 2020 | 22 | 2020 |
| Comparison of DNA demethylating and histone deacetylase inhibitors hydralazine-valproate versus vorinostat-decitabine incutaneous t-cell lymphoma in HUT78 cells A Schcolnik-Cabrera, G Domínguez-Gómez, A Dueñas-González American journal of blood research 8 (2), 5, 2018 | 22 | 2018 |
| Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature G Rodríguez-Gutiérrez, EM Carrillo-Casas, R Arenas, JO García-Méndez, ... Mycopathologia 180, 89-93, 2015 | 18 | 2015 |
| Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: the Mexican experience A Schcolnik-Cabrera, N Labastida-Mercado, LS Galindo-Becerra, ... Hematology 20 (5), 263-266, 2015 | 16 | 2015 |
| Lipotransferencia complicada con micobacteriosis atípicas. Reporte de dos casos y revisión de la literatura AS Cabrera, RH Castro, MEV Memije, RA Guzmán, RFF Martínez Gaceta Médica de México 150 (s3), 311-316, 2014 | 12 | 2014 |
| A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells A Schcolnik‑Cabrera, G Dominguez‑Gómez, A Chávez‑Blanco, ... Oncology letters 18 (6), 6909-6916, 2019 | 11 | 2019 |
| The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells A Schcolnik‑Cabrera, A Chavez‑Blanco, G Dominguez‑Gomez, M Juarez, ... Oncology letters 20 (3), 3053-3060, 2020 | 8 | 2020 |
| Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer A Schcolnik-Cabrera, D Juárez-López Cellular Oncology 45 (5), 831-859, 2022 | 6 | 2022 |
| Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy A Schcolnik-Cabrera, A Chavez-Blanco, G Dominguez-Gomez, M Juarez, ... Scientific Reports 11 (1), 5222, 2021 | 6 | 2021 |
| In vitro employment of recombinant taenia solium calreticulin as a novel strategy against breast and ovarian cancer stem-like cells A Schcolnik-Cabrera, M Juárez, B Oldak, M Cruz-Rivera, A Flisser, ... Archives of Medical Research 51 (1), 65-75, 2020 | 6 | 2020 |
| The cost of beauty: six cosmetological clinical cases due to atypical mycobacterial infection secondary to intradermal injections plus reaction to foreign dermal implant A Schcolnik-Cabrera, E Vega-Memije, R Hernandez-Castro, R Arenas, ... Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de …, 2019 | 6* | 2019 |
Alfonso Duenas-GonzalezUnit of Biomedical Research on Cancer, Instituto de Investigaciones Biomedicas UNAM, InstitutoVerified email at incan.edu.mx
